Novartis India to buy Pfizer's Minipress trademarks for about ₹1,250 crore
Novartis India announced the purchase of Pfizer's Minipress and Minipres trademarks for roughly ₹1,250 crore. The company's board approved the transaction. The Minipress XL product had recorded ₹228.6 crore in revenue by July 2026.